Substanzen · Phenethylamin-Derivate
2-FMA
- Bevorzugter Name
- 2-FMA
- IUPAC-Name
- 1-(2-fluorophenyl)-N-methylpropan-2-amine
- CAS-Nummer der Stammverbindung (Referenz)
- 1017176-48-5
- Summenformel
- C10H14FN
- Molekulargewicht
- 167.22 g/mol
- InChIKey
- XNWIKJYFOIDUGD-UHFFFAOYSA-N
- PubChem
- CID 24257263
- Quelle
- PubChem
- Geprüfte Synonyme und Katalogkürzel
-
2-Fluoromethamphetamine 2FMA 2 FMA
Passende Artikel im aktuellen Shop-Katalog
Geprüftes Pharmakologie- & Toxikologie-Dossier
2-FMA
Rezeptor-Telemetrie & Wirkmechanismus
2-FMA is the ortho-fluoro analogue of methamphetamine and the N-methyl homologue of 2-FA. Published human transporter numbers are sparse. The observed profile is a long, functional dopamine/norepinephrine stimulant with little serotonergic warmth: focus, wakefulness, appetite loss, and a flat mood rather than an MDMA-like roll. It is less mood-elevating than 3-FA or 4-FA and much less entactogenic than 4-FMA.
Biotransformation & Active Metabolites
Presumed to undergo typical amphetamine N-demethylation and oxidative deamination. It is not a prodrug of 2-FA in any quantitative brackets sense, and a 2-FA oral chart (common 30–50 mg, 2–4 hours) does not describe this longer compound.
Zeitliche Pharmakokinetik
Long, clear, low-elevated dopaminergic tone stimulant. Wakefulness and task focus with vasoconstriction and a hard offset, not an entactogen.
- Onset 30–60 minutes
- Peak Window 2.5–4 hours
- Total Window 7–9 hours
- Residual / Half-Life Residual stimulation 4–12 hours. A formal human half-life is not published; the practical problem is next-night insomnia.
Oral threshold 5 mg, light 5–15 mg, common 15–30 mg, strong 30–50 mg, heavy above 50 mg. The total course is 7–9 hours with 4–12 hours of after-effects. A second dose taken to extend the afternoon lands in the insomnia window.
Quantitatives Wirkungsspektrum (Literaturdaten)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
5 mg
Slight wakefulness and a cleaner attention span.
Mild appetite loss and a small pulse increase.
5–15 mg
Functional alertness, motivation, and little emotional color.
Dry mouth, cold fingers, and suppressed hunger.
15–30 mg
Sustained focus, talkativeness without much elevated dopaminergic tone, and a forced wakefulness that outlasts the useful part.
Tachycardia, blood-pressure rise, bruxism, and sweating.
30–50 mg
Scattered focus, irritability, and stimulant anxiety replacing the 'clean' feeling.
Pronounced vasoconstriction, tremor, urinary hesitation, and a long inability to sleep.
50 mg+
Agitation, paranoia, and compulsive repeated exposure thoughts.
Hypertensive strain, chest tightness, severe insomnia, and seizure risk with tramadol or an MAOI.
Wechselwirkungsmatrix — Niemals kombinieren
Lebensgefahr — Niemals kombinieren
Blocking monoamine breakdown while a releaser or a catecholamine uptake inhibitor is active can produce a hypertensive crisis and, for the serotonergic members, serotonin toxicity.
Adds extreme vasoconstriction and seizure risk on top of an already raised heart rate and blood pressure.
Both lower the seizure threshold. Tramadol also adds serotonin reuptake inhibition, which is dangerous with the serotonergic releasers in this set.
Hohes Risiko — Vermeiden
Additive tachycardia, hypertension, bruxism, and post-session anxiety without restoring a faded peak.
The stimulant hides sedation. When it drops, the depressant remains.
Vorsicht / Abschwächung
Often increases heart rate and paranoid thought on the offset.
Blunt the serotonergic portion of entactogen-type members while the cardiovascular load stays. They are not protection against serotonin toxicity.
Isomeren- & Strukturvergleich
2-FMA is the long functional fluoro stimulant: common 15–30 mg oral and 7–9 hours, little serotonin. 4-FMA (common 50–100 mg) is more entactogenic and more concerning for the heart. 3-FA (common 30–50 mg, 4–6 hours) is more classically mood-elevating and dopaminergic. 4-FA becomes entactogenic only around 100 mg and has a stroke signal above the strong band. None of those oral numbers are interchangeable.
Stabilität & Lagerung
Form: White, off-white, or pale tan crystalline powder, shards, or clumps as the hydrochloride or another salt. Not a plant blend. · Hydrochloride salts dissolve in water and alcohols. Succinate salts of the benzofurans also dissolve in water but contain less active amine per milligram.
Airtight, cool, dry, and dark. Some salts are hygroscopic and clump. A clump is not a reason to guess the mass.
Cross-Tolerance & Dependence Profile
Dopaminergic stimulant tolerance builds with repeated days, halves over roughly 3–7 days, and approaches baseline in 1–2 weeks, with cross-tolerance to amphetamines and other catecholamine stimulants. Psychological dependence and crash fatigue are the dependence pattern. It does not reset serotonin the way an MDMA weekend does, but daily use still produces a flat, vasoconstricted insomnia cycle.
Chemische Struktur und Molekülprofil
2-FMA (1-(2-fluorophenyl)-N-methylpropan-2-amine) ist eine Referenzverbindung aus der Stoffklasse Phenethylamin-Derivate mit der Summenformel C10H14FN und einer molaren Masse von 167.22 g/mol. Die Stammverbindung wird unter der CAS-Nummer 1017176-48-5 sowie in der NCBI-PubChem-Datenbank unter CID 24257263 geführt (Standard-InChIKey: XNWIKJYFOIDUGD-UHFFFAOYSA-N). Diese Verbindung teilt ihre Summenformel (C10H14FN) mit Konstitutions- oder Positionsisomeren; die eindeutige Identifizierung erfolgt über den vollständigen IUPAC-Namen und die CAS-Nummer (1017176-48-5).
Quellen
- PubChem — PubChem (2026-11-12)
Referenztoxikologie und Sicherheitsprofil
Laut dokumentierten Referenzdaten (PubChem / PsychonautWiki, CC BY 4.0) gehört 2-FMA zur chemischen Klasse Amphetamine, Substituted amphetamines. Toxikologische Hinweise (PsychonautWiki): die genaue toxische Schwelle ist in der Fachliteratur nicht festgelegt. Abhängigkeitspotenzial (PsychonautWiki): mäßiges Abhängigkeitspotenzial bei wiederholter Exposition. Dokumentierte Kreuztoleranz: dopamine, stimulant. Beim Umgang im Labor sind geeignete persönliche Schutzausrüstung und das Sicherheitsdatenblatt (SDB) zu beachten.
Quellen
- PubChem — PubChem (2026-11-12)
Analytischer Verwendungszweck und Laborhinweis
Dieses Datenblatt dient ausschließlich der chemischen, analytischen und toxikologischen Dokumentation. Das Material ist nicht für den menschlichen Verzehr bestimmt. Ein Forschungshinweis begründet keinen Rechtsstatus.
Quellen
- Gesetze im Internet — Neue-psychoaktive-Stoffe-Gesetz (NpSG) & BtMG — Bundesministerium der Justiz (2026-11-12)